SCHEMBL362992

SCHEMBL362992

Cc1cc(/C(CC(c2ccc(C(=O)NC3CC3)cc2)c2ccc(F)cc2F)=N/O)ccn1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 4/20 0.67
RORC P51449 1/20 0.40
MCHR1 Q99705 2/20 0.38
HSD11B1 P28845 1/20 0.37
MAPK14 Q16539 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
DPP4 P27487 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
HTR2B P41595 1/20 0.36
SMYD3 Q9H7B4 1/20 0.36
CCNE1 P24864 2/20 0.35
CDK2 P24941 2/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK11 Q15759 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389782 1.00 GPBAR1 (0.67) GPBAR1RORCMCHR1HSD11B1MAPK14
SCHEMBL1389784 1.00 GPBAR1 (0.67) GPBAR1RORCMCHR1HSD11B1MAPK14
SCHEMBL1389968 0.96 GPBAR1 (0.64) GPBAR1RORCHSD11B1NPC1RAB9A
SCHEMBL362388 0.96 GPBAR1 (0.64) GPBAR1RORCHSD11B1NPC1RAB9A
SCHEMBL1389966 0.96 GPBAR1 (0.64) GPBAR1RORCHSD11B1NPC1RAB9A
SCHEMBL1389950 0.94 GPBAR1 (0.61) GPBAR1RORCMCHR1
SCHEMBL363755 0.90 GPBAR1 (0.53) GPBAR1RORCMCHR1HSD11B1MAPK14
SCHEMBL363824 0.87 GPBAR1 (0.63) GPBAR1MAPK14MAPK11
SCHEMBL1389999 0.87 GPBAR1 (0.63) GPBAR1MAPK14MAPK11
SCHEMBL1389995 0.87 GPBAR1 (0.63) GPBAR1MAPK14MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP claimed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885RORC 2041/4885MCHR1 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.